MAPK3 and liver cancer: In conclusion, this study indicates for the first time to the best of our knowledge, that miR-101 can inhibit the phosphorylation level of ERK1/2 through targeted inhibition on EZH2, ultimately suppressing the proliferation of liver cancer cells.